To determine the clinical relevance of the lncRNA SCIRT/miR-665/HEYL pathway, we analyzed The Cancer Genome Atlas (TCGA) database and identified significant upregulation of SCIRT and miR-665 and downregulation of HEYL in lung cancer tissues (Figures 5(a) and 5(c)). This evidence concerns the gene HEYL and lung carcinoma.